Partner/Owner

Representative before the EPO

Employment test 11 - 50 employees
Company dna kraus and weisert patentanwalte partgmbb
operating since 1974
Headquarter in Munich
active in Legal Services and IP Consulting

Inge Hiebl has worked on the following 96 EPO patent applications which have been published in the last five years:

EP10837676

CYSTATIN C, BETA2 MICROGLOBULIN, ALPHA1 MICROGLOBULIN AND GENES FOR SAME, ANTIBODY, AND KIT AND METHOD FOR DIAGNOSIS OF FELINE NEPHROPATHY

IPC classification:
C07K 14/81, C07K 16/38, C12N 15/09, G01N 33/53
Applicant:
Nipro Corporation (Nipro Kabushiki-gaisha)
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP11726386

ACETYL-CARNITINE FOR USE IN A METHOD FOR INCREASING NEUROGENESIS IN NEURAL TISSUE

IPC classification:
A61K 31/21, A61P 25/16, A61P 25/28
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP11823705

HUMAN-DERIVED CELL-PERMEABLE PEPTIDE BIOACTIVE PEPTIDE CONJUGATE, AND USE THEREOF

IPC classification:
A61K 38/08, A61P 19/00, C07K 7/06, C07K 7/08
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP12182318

Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer

IPC classification:
A01N 65/00, A61K 36/38, A61K 36/47
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP11776879

PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN, PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/44
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP11788175

COMPOSITION FOR TOPICAL USE FOR TREATING SKIN DISORDERS

IPC classification:
A61K 31/205, A61K 31/355, A61K 31/4188, A61K 31/714, A61P 17/00, A61P 17/02, A61P 17/04, A61P 17/06, A61P 17/08, A61P 17/10
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12716038

COMPOSITION USEFUL FOR THE TREATMENT OF LIPID METABOLISM DISORDERS

IPC classification:
A61K 31/045, A61K 31/05, A61K 31/122, A61K 31/202, A61K 31/205, A61K 31/4415, A61K 31/714, A61K 36/062, A61K 36/899
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11866566

CELL-PENETRATING FUSION PROTEIN FOR REGENERATING OR PROLIFERATING STEM CELL

IPC classification:
A61P 19/00, C07K 19/00, C12N 15/62
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13157592

Biomarkers for melanoma

IPC classification:
C12Q 1/68
Applicant:
Johns Hopkins University
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13157659

Biomarkers for melanoma

IPC classification:
C12Q 1/68
Applicant:
Johns Hopkins University
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION WITHDRAWN
EP12738335

TREATMENT FOR HYPOXIA

IPC classification:
A61K 31/34, A61P 43/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12761650

PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS

IPC classification:
A61K 9/00, A61K 9/02, A61K 9/20
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12740137

PHARMACEUTICAL COMPOSITION OF OXIDISED AVIDIN SUITABLE FOR INHALATION

IPC classification:
A61K 9/00, A61K 47/42, A61P 35/00
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12821615

BILIRUBIN EXCRETION ENHANCER

IPC classification:
A61K 38/00, A61P 39/02, C07K 14/765
Applicant:
Nipro Corporation (Nipro Kabushiki-gaisha)
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP12756550

METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE

IPC classification:
C12Q 1/68
Applicant:
UCL Business plc
Applicant:
University College Cardiff Consultants Limited
Applicant:
VU University Medical Center Amsterdam (VU Medisch Centrum)
Applicant:
University of Manchester
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP12807992

TASTE-IMPROVING PEPTIDE

IPC classification:
A23L 1/22, A23L 1/227
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12761967

NEW THIO DERIVATIVES BEARING LACTAMS AS POTENT HDAC INHIBITORS AND THEIR USES AS MEDICAMENTS

IPC classification:
A61K 31/397, A61K 31/4015, A61K 31/45, A61K 31/4709, A61P 25/00, A61P 29/00, A61P 33/00, A61P 35/00, C07D 205/08, C07D 207/277, C07D 207/28, C07D 211/78, C07D 401/04
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12839059

COMPOSITE SUGAR CHAIN HYDROLASE

IPC classification:
C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 9/24, C12N 15/09, C12P 21/02
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13185358

siRNA conjugate and preparation method thereof

IPC classification:
A61K 48/00, C07H 21/02, C12N 15/11, C12N 15/87
Applicant:
Bioneer Corporation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP14162248

Fusion molecules and IL-15 variants

IPC classification:
C07K 14/00, C07K 14/54, C07K 14/715, C12N 15/62
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12784848

METHODS OF BLOCKING CANCER STEM CELL GROWTH

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/30
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12784847

ANTIBODIES AND METHODS OF TREATING CANCER

IPC classification:
A61K 39/395, C07K 16/28
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12787287

ANTI-GPR49 ANTIBODIES

IPC classification:
C07K 16/28
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12783481

ANTI-GPR49 ANTIBODIES

IPC classification:
C07K 16/28
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12795971

THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE

IPC classification:
A61K 31/713, C12N 15/113
Applicant:
The Regents of the University of California
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12795973

AUTO -RECOGNIZING THERAPEUTIC RNA/DNA CHIMERIC NANOPARTICLES (NP)

IPC classification:
C12N 15/11, C12N 15/113
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12857435

METHOD FOR FINDING BIOACTIVE PEPTIDES

IPC classification:
C07K 1/14, G01N 33/52, G01N 33/53, G01N 33/68
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12857568

NOVEL OLIGONUCLEOTIDE CONJUGATES AND USE THEREOF

IPC classification:
A61K 9/16, A61K 47/48, A61K 48/00, C12N 15/11
Applicant:
Bioneer Corporation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13733748

HIGH-EFFICIENCY NANOPARTICLE-TYPE DOUBLE-HELICAL OLIGO-RNA STRUCTURE AND METHOD FOR PREPARING SAME

IPC classification:
A61K 31/7105, C07H 21/02, C12N 15/11, C12Q 1/68
Applicant:
Bioneer Corporation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12859499

METHOD FOR PRODUCING NATURAL KILLER CELLS, NATURAL KILLER CELLS PRODUCED THEREBY, AND COMPOSITION FOR TREATING CANCERS AND INFECTIOUS DISEASES CONTAINING THE SAME

IPC classification:
A61K 35/56, A61P 35/00, C12N 5/02, C12N 5/0783
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12790065

SELECTIVE ULTRASONIC LYSIS OF BLOOD AND OTHER BIOLOGICAL FLUIDS AND TISSUES

IPC classification:
C12N 13/00, C12Q 1/04, C12Q 1/68
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13704538

CDK8/CDK19 SELECTIVE INHIBITORS AND THEIR USE IN ANTI-METASTATIC AND CHEMOPREVENTATIVE METHODS FOR CANCER

IPC classification:
A61K 31/517, A61P 35/00, C07D 239/94
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13752075

MODIFIED ANTIBODY IN WHICH MOTIF COMPRISING CYSTEINE RESIDUE IS BOUND, MODIFIED ANTIBODY-DRUG CONJUGATE COMPRISING THE MODIFIED ANTIBODY, AND PRODUCTION METHOD FOR SAME

IPC classification:
A61K 39/395, A61K 47/42, A61K 47/48, C07K 16/28
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12870276

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATIC FIBROSIS AND CIRRHOSIS CONTAINING RAMALIN

IPC classification:
A61K 31/17, A61K 31/175, A61P 1/00, A61P 1/16
Applicant:
Korea Institute of Ocean Science and Technology (KIOST)
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP12718446

METHOD FOR ENHANCING EFFICACY AND SELECTIVITY OF CANCER CELL KILLING BY DNA DAMAGING AGENTS

IPC classification:
A61K 31/704, A61K 35/00, A61P 35/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13749307

VIRUS LIKE PARTICLE COMPOSITION

IPC classification:
A61K 39/00, A61P 35/00, A61P 37/00, C07K 14/18, C07K 14/525, C07K 14/705, C07K 19/00, C12N 15/09, C12P 21/08
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP11863809

SURFACE-ACTIVE COLLAGEN MEMBRANE BY PEPTIDE

IPC classification:
A61K 38/39, A61L 27/24, C07K 14/47, C07K 14/78, C07K 19/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13757504

COMPOSITION FOR HOT-START REVERSE TRANSCRIPTION REACTION OR HOT-START REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION

IPC classification:
C12Q 1/42, C12Q 1/48, C12Q 1/68
Applicant:
Bioneer Corporation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP11742698

SYSTEM AND METHOD FOR LASER DISSECTION

IPC classification:
G01N 1/04, G01N 1/06, G01N 1/28, G01N 1/31, G01N 1/42
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13775206

COMPOSITIONS AND METHODS FOR QUANTIFYING A NUCLEIC ACID SEQUENCE IN A SAMPLE

IPC classification:
C12N 15/11, C12Q 1/00, C12Q 1/68
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13777949

METHOD FOR MANUFACTURING STEM CELL HAVING APPROPRIATE SIZE FOR INTRAVASCULAR ADMINISTRATION

IPC classification:
C12N 5/02, C12N 5/074, C12N 5/0775
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP13182338

Mildronate in ophthalmic disorders

IPC classification:
A61K 31/205, A61P 27/02, A61P 27/06
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13781861

STEM CELL CULTURE MEDIUM AND METHOD FOR CULTURING STEM CELLS USING SAME

IPC classification:
C12N 5/02, C12N 5/074
Applicant:
Samsung Life Public Welfare Foundation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14182568

Cell permeable fusion protein for facilitating reprogramming induction and use thereof

IPC classification:
C07K 14/47, C12N 5/074, C12N 15/62
Applicant:
Seoul National University Research & Development Business Foundation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13793724

COMPOSITIONS AND METHODS FOR ASSAYING PLATELET REACTIVITY AND TREATMENT SELECTION

IPC classification:
G01N 33/48, G01N 33/53, G01N 33/68, G01N 33/96
Applicant:
The University of Vermont and State Agriculture College
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP11174893

Process of lysing yeast cell walls

IPC classification:
C12G 1/00, C12N 1/06, C12N 9/34
Applicant:
AB Enzymes GmbH
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION REFUSED
EP13805033

NOVEL ANTIBODY SPECIFIC FOR CLEC14A AND USES THEREOF

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C12N 15/13
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13807259

METHOD FOR PREPARING PATIENT-SPECIFIC GLIOBLASTOMA ANIMAL MODEL, AND USE THEREOF

IPC classification:
A01K 67/027, C12N 15/09, G01N 33/15
Applicant:
Samsung Life Public Welfare Foundation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13810037

HIGH-CONCENTRATION STEM CELL PRODUCTION METHOD

IPC classification:
C12N 5/02, C12N 5/0775
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10803635

COMPOSITIONS COMPRISING NONSTEROIDAL ANTI-INFLAMMATORY DRUGS

IPC classification:
A61K 9/08, A61K 31/192, A61K 47/36, A61K 47/38
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13739813

PHARMACEUTICAL COMPOSITIONS COMPRISING RIFAXIMIN AND AMINO ACIDS, PREPARATION METHOD AND USE THEREOF

IPC classification:
A61K 9/00, A61K 31/437, A61K 47/18, A61P 31/00, C07D 498/22
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP13753973

EXPRESSION OF PROTEIN-CODING AND NONCODING GENES AS PROGNOSTIC CLASSIFIERS IN EARLY STAGE LUNG CANCER

IPC classification:
C12Q 1/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13773263

MODIFIED HYALURONIC ACID DERIVATIVES AND USE THEREOF

IPC classification:
A61K 8/73, A61K 31/728, A61Q 19/00, C08B 37/00
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP13795625

METHOD FOR TREATING PROSTATE CANCER

IPC classification:
A61K 31/517, A61K 31/5377, C07D 239/94
Applicant:
University of South Carolina
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP15162957

MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 38/00, A61K 38/17, A61K 38/20, A61P 35/00, C07K 14/075, C07K 14/54, C07K 14/715, C07K 16/18, C07K 19/00, C12N 1/00, C12N 5/00, C12N 15/62
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13858370

APPARATUS FOR AUTOMATICALLY PREPARING CELL-FREE PROTEINS AND METHOD FOR PREPARING PROTEINS USING SAME

IPC classification:
C07K 1/22, C12M 1/38
Applicant:
Bioneer Corporation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13814970

GENES/GENETIC ELEMENTS ASSOCIATED WITH MATING IMPAIRMENT IN TRICHODERMA REESEI QM6A AND ITS DERIVATIVES AND PROCESS FOR THEIR IDENTIFICATION

IPC classification:
C07K 14/37, C12N 1/14, C12N 15/80, C12R 1/885
Applicant:
AB Enzymes GmbH
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP10832410

A BIODEGRADABLE EXPANDED POLYSTYRENE FOAM AND METHOD FOR ITS PRODUCTION

IPC classification:
B29B 17/04, C08F 8/50, C08J 7/04, C08J 11/10
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14001940

Solid formulations containing resveratrol and omega-3 polyunsaturated fatty acids (n-3 PUFA)

IPC classification:
A61K 9/16, A61K 9/20, A61K 31/00
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP14001941

Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration

IPC classification:
A61K 9/08, A61K 31/05, A61K 47/12, A61K 47/24
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP15164007

COMPOSITIONS AND METHODS FOR CHARACTERIZING A MYOPATHY

IPC classification:
G01N 33/15, G01N 33/532, G01N 33/534, G01N 33/564, G01N 33/573
Applicant:
Johns Hopkins University
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP14713958

INHIBITORS OF CDK8/19 FOR USE IN TREATING ESTROGEN RECEPTOR POSITIVE BREAST CANCER

IPC classification:
A61K 31/00, A61K 31/517, A61K 45/06, A61P 35/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14778792

ASSAYS AND METHODS FOR SELECTING A TREATMENT REGIMEN FOR A SUBJECT WITH DEPRESSION

IPC classification:
G06F 19/22
Applicant:
Nestec S.A.
Agent:
Sri Krishnan, Nestec S.A.
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Agent:
Solveig Helga Moré, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Status:
EXAMINATION REQUESTED
EP14723122

NSAID ADMINISTRATION AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

IPC classification:
A61K 9/16, A61K 31/395, A61K 31/439, A61P 1/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15173589

BIOMARKERS FOR OVARIAN CANCER: BETA-2 MICROGLOBULIN

IPC classification:
A61K 39/00, G01N 33/574, G01N 33/68
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP12702953

MULTIVALENT VACCINES FOR RABIES VIRUS AND FILOVIRUSES

IPC classification:
A61K 39/12, A61K 39/295, C12N 7/00, C12N 15/86
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14200601

Cold-adapted protease derived from pseudoalteromonas arctica PAMC 21717 and uses thereof

IPC classification:
A01N 63/02, A61K 38/46, C12N 9/14, C12N 9/16, C12N 15/09
Applicant:
Korea Institute of Ocean Science and Technology (KIOST)
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13183542

Stable liquid oily ready-to-use formulations, preparation thereof and use thereof

IPC classification:
A61K 9/10, A61K 31/401, A61K 31/4439, A61K 47/44
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15193745

ANTIBODIES AGAINST GLUCAGON RECEPTOR AND THEIR USE

IPC classification:
C07K 16/28, C07K 16/46, C12N 5/12
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP14185003

Therapeutic and nutritional compositions for functional gastrointestinal disorders

IPC classification:
A61K 36/235, A61K 36/9066, A23L 5/00, A23L 33/105
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP11754418

THERAPEUTICAL METHOD FOR THE TREATMENT OF THE LEBER OPTIC NEUROPATHY

IPC classification:
A61K 31/221, A61P 27/02
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11799845

SOLID COMPOSITIONS CONTAINING FLURBIPROFEN, THE PROCESSES FOR THEIR PREPARATION AND THEIR USE.

IPC classification:
A61K 9/00, A61K 9/20, A61K 31/192
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14845394

METHODS AND COMPOSITIONS RELATING TO CANCER THERAPY WITH DNA DAMAGING AGENTS

IPC classification:
C12Q 1/68
Applicant:
University of Chicago
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP16152616

METHOD FOR DETERMINING ANDROGEN RECEPTOR VARIANTS IN PROSTATE CANCER

IPC classification:
G01N 33/574
Applicant:
Johns Hopkins University
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP10858254

COMPOSITIONS AND METHODS FOR DIAGNOSING AUTISM

IPC classification:
C12N 15/12, C12Q 1/68
Applicant:
The General Hospital Corporation
Applicant:
Johns Hopkins University
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11823701

PEPTIDE HAVING THE ABILITY TO REGENERATE BONE TISSUE AND FOR BINDING TO APATITE

IPC classification:
A61F 2/28, A61L 27/12, A61L 27/22, C07K 19/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14799726

COMPOSITION USEFUL FOR PROMOTING FEMALE FERTILITY

IPC classification:
A61K 31/07, A61K 31/195, A61K 31/198, A61K 31/205, A61K 31/355, A61K 31/375, A61K 31/4415, A61K 31/525, A61K 31/592, A61K 31/593, A61K 31/714, A61K 33/04, A61K 33/26, A61K 33/30, A61K 33/34
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP12163883

DNA methylation markers and methods of use

IPC classification:
C12Q 1/68
Applicant:
Johns Hopkins University
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10834099

METHOD FOR MAKING A FLOOR COVERING

IPC classification:
D05C 17/02, D06N 7/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10788312

ANTICANCER COMBINATION OF ARTEMISININ-BASED DRUGS AND OTHER CHEMOTHERAPEUTIC AGENTS

IPC classification:
A61K 31/24, A61K 31/335, A61K 31/4745, A61K 31/704, A61P 35/00
Applicant:
Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Giulia Tagliafico, Sigma-Tau Industrie Farmaceutiche Riunite SpA
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11164159

Sol-gel kit for preparing biochip and method for preparing biochip using the same

IPC classification:
B01J 19/00, G01N 33/543, G01N 33/552
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15751458

NEW ANTI-HUMAN PAI-1 ANTIBODY

IPC classification:
A61K 39/395, A61P 7/02, A61P 11/00, A61P 41/00, C07K 16/38, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08
Applicant:
Astellas Pharma Inc.
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14885531

METHOD FOR PURIFYING IMMUNOGLOBULIN

IPC classification:
C07K 1/18, C07K 16/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14885344

METHOD FOR PURIFYING IMMUNOGLOBULIN

IPC classification:
C07K 1/18, C07K 1/30, C07K 1/34, C07K 1/36, C07K 16/00
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP16187004

CRYSTALLINE FORMS OF RIFAXIMIN AND THEIR PREPARATION IN THE PRESENCE OF AMINO ACIDS

IPC classification:
C07D 498/22
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION PUBLISHED
EP15774211

HUMANIZED ANTIBODIES THAT BIND LGR5

IPC classification:
C07K 16/28
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15785500

ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES

IPC classification:
A61K 39/395, A61P 37/00, C07K 16/18, C07K 16/46, C12N 15/13, C12N 15/63, G01N 33/53
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15726344

NEW SOLVATED CRYSTAL FORM OF RIFAXIMIN, PRODUCTION, COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/437, A61P 1/12, A61P 31/04, C07D 498/22
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15815195

METHODS FOR RETREATING IRRITABLE BOWEL SYNDROME (IBS)

IPC classification:
A61K 31/437, A61K 36/47, A61P 1/00, A61P 1/12
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15193477

ENGINEERED HYBRID CEMENT-BASED COMPOSITION WITH INCREASED WETTING RESISTANCE

IPC classification:
C04B 24/14, C04B 28/02, C04B 28/10
Applicant:
Technische Universität München
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION PUBLISHED
EP15819275

MULTI-INFLUENZA DETECTION KIT AND METHOD FOR DETECTING INFLUENZA USING THE SAME

IPC classification:
C12Q 1/68, G01N 21/78, G01N 33/52, G01N 33/53
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP17157159

USE OF POLYOLS TO OBTAIN STABLE POLYMORPHOUS FORMS OF RIFAXIMIN

IPC classification:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 9/50, A61K 31/437, A61K 47/10, A61K 47/26, A61K 47/36, A61K 47/38
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
APPLICATION PUBLISHED
EP17157804

TARGET SUBSTANCE DETECTION METHOD USING APTAMER

IPC classification:
C12N 15/11, C12N 15/115, C12Q 1/68, G01N 27/414, G01N 33/52, G01N 33/543
Applicant:
Dongguk University Industry-Academic Cooperation Foundation
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
The application has been published
EP15845586

KIT FOR MEASURING TITER OF A PROTEIN COMPRISING HUMAN FC USING INDIRECT ELISA AND METHOD FOR MEASURING TITER OF A PROTEIN COMPRISING HUMAN FC USING THE SAME

IPC classification:
G01N 33/53, G01N 33/68
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made
EP16204118

METHOD FOR DIAGNOSING A NEURODEGENERATIVE DISEASE

IPC classification:
A61K 38/17, C12Q 1/68, G01N 33/50, G01N 33/68
Applicant:
University College Cardiff Consultants Limited
Applicant:
VU University Medical Center Amsterdam (VU Medisch Centrum)
Applicant:
University of Manchester
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
The application has been published
EP15862930

METHOD FOR CULTURING NATURAL KILLER CELLS USING T CELLS

IPC classification:
A61K 35/14, A61P 31/00, A61P 35/00, C12N 5/02, C12N 5/0783
Agent:
Inge Hiebl, Kraus & Weisert Patentanwälte PartGmbB
Status:
Request for examination was made

Please Sign in to use this feature